Participant Counts With One Common Control

Counting Participants When Treatments Share a Control

Suppose a study will compare several experimental treatments with the same control condition. If every group is planned to have the same number of participants, the total is found by counting each treatment group and the common control group once. The important bookkeeping point is that the control participants are shared across comparisons: they are not recruited again for each treatment.

This calculation answers a specific question: how many unique participants are planned under a stated group size? It does not determine whether that group size is sufficient for the scientific aims. The required number per group must come from an appropriate sample-size plan for the comparisons; here, we take that number as given and calculate the resulting recruitment total.

For comparison, \(k\) separate two-arm trials, each with \(n\) participants in its treatment group and \(n\) in its own control group, plan \(2n\) participants per trial. If the separate trials recruit distinct participants, their combined recruitment is \(2kn\). Thus the two totals being compared are \((k+1)n\) for one multi-arm design with a shared control and \(2kn\) for \(k\) separate trials. The comparison relies on using the same \(n\) in each group in both plans.

How the Count Is Built

The total is a sum over the groups actually recruited. Let the common control contain \(n\) participants, and let each of the \(k\) treatment groups also contain \(n\). Adding the control and treatment-group counts gives:

For separate trials, each trial has one treatment group and a distinct control group, so its total is \(n+n=2n\). Adding the totals for \(k\) trials gives:

This is a count, not a model for treatment effects. The calculation assumes equal group sizes and a control condition that is genuinely common across the treatment comparisons. It also assumes that the separate-trial comparison means separate sets of participants: if control participants are actually reused across trials, those are no longer separate, non-overlapping recruitment totals.

Two Treatments: Count the Control Once

With two experimental treatments, the common-control design contains three groups: treatment 1, treatment 2, and control. The separate-trial plan contains two trials, each with its own treatment group and control group. Keeping these group structures visible is often the easiest way to prevent a counting error.

A common incorrect count for the shared-control plan is \(2(50+50)=200\), because it assigns a new control group to each treatment comparison. That count describes two separate trials, not one design with a single common control. In the shared-control design, the same 50 control participants serve both comparisons and enter the unique-participant total once.

Three Treatments: Add One More Treatment Group

With three experimental treatments and one common control, there are four groups in the multi-arm design. The separate-trial comparison has three two-arm trials. If group sizes are equal, the same counting process applies: add the four groups once for the shared-control total, and add three two-group trial totals for the separate-trial total.

Checking a Plan Before Reporting Its Total

A recruitment total is only interpretable when its counting assumptions are clear. Before using the formulas, check the group structure, the meaning of \(n\), and what is being compared. The following checklist keeps the arithmetic connected to the design.

For example, if an analysis needs 64 participants per group but some randomized participants may not provide usable outcomes, the planned randomized total might need separate consideration. The simple counts above do not add a dropout allowance or other recruitment buffer. Likewise, they do not account for different required sample sizes across treatment comparisons.

Assumptions, Diagnostics, and Limits

The count \((k+1)n\) is appropriate when there is one shared control group and \(k\) treatment groups, all with \(n\) participants. The treatment comparisons must refer to the same control condition for it to be meaningful to treat that group as common. The comparison with \(2kn\) further assumes that the separate trials use the same group size \(n\) and recruit non-overlapping participants.

Check the plan for practical or design features that break those assumptions. A control group may not be common if the control intervention, eligibility criteria, or study setting differs across treatment comparisons. If the treatment groups have different target sizes, the total must instead be calculated by summing the actual group sizes. If separate trials reuse participants, their combined number of unique participants cannot be obtained by simply adding each trial's total. These are signs to revisit the group list rather than apply the equal-size formulas mechanically.

The main alternative considered here is running separate two-arm trials, each with its own control. That approach can make each trial's recruitment straightforward to describe, but its combined count includes a control group for every trial. A shared-control design instead plans one control group for all the treatment comparisons. The count comparison does not settle which design is preferable: it does not assess operational constraints, whether a control can appropriately be shared, or whether the sample size is adequate for the intended analyses.

A related mistake is to interpret a smaller recruitment total as evidence that a design automatically has adequate power or precision. The arithmetic here takes \(n\) as specified. Whether that value is suitable depends on the scientific comparison and its sample-size assumptions, which are not established by adding group counts. Always report both the group sizes and the total so that the structure behind the number is transparent.